Defibrillation threshold testing: Tradition or necessity?

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 5, 2009, Pages 570-572

  Kolb, Christof ^a,b   Tzeis, Stylianos ^a   Zrenner, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Defibrillation threshold testing; Implantable cardioverter defibrillator; Sudden cardiac death

Indexed keywords

DEFIBRILLATION; DEFIBRILLATOR; ENERGY; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MORTALITY; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE ANALYSIS; HUMANS; PROSTHESIS IMPLANTATION;

EID: 65649130785     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02328.x     Document Type: Review

References (19)

1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006 8 : 746 837.
2. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, Tu JV, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A meta-analysis. J Am Coll Cardiol 2003 41 : 1573 1582. (Pubitemid 36543378)
3. Nanthakumar K, Epstein A, Kay N, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction. A pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004 44 : 2166 2172. (Pubitemid 39576036)
4. Marchlinski FE, Flores B, Miller JM, Gottlieb CD, Hargrove WC III. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988 62 : 393 398. (Pubitemid 18207236)
5. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007 30 : 675 700. (Pubitemid 46656108)
6. Lever NA, Newall EG, Larsen PD. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007 9 : 1054 1058.
7. Qin H, Walcott GP, Killingsworth CR, Rollins DL, Smith WM, Ideker RE. Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery. Circulation 2002 105 : 2537 2542.
8. Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR, INTRINSIC RV Study Investigators. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace 2008 10 : 347 350.
9. Schuger C, Ellenbogen K, Faddis M, Knight BP, Yong P, Sample R VENTAK CHF/CONTAK CD Study Investigators. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006 17 : 247 250. (Pubitemid 43344931)
10. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, et al. Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005 2 : 456 461. (Pubitemid 40521355)
11. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, Payne J, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the low energy safety study (LESS). Circulation 2002 105 : 2043 2048. (Pubitemid 34465266)
12. Pinski SL, Vanerio G, Castle LW, Morant VA, Simmons TW, Trohman RG, Wilcoff BL, et al. Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome. Am Heart J 1991 122 : 89 95.
13. Windecker S, Ideker RE, Plumb VJ, Kay GN, Walcott GP, Epstein AE. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in human. J Am Coll Cardiol 1998 33 : 33 38.
14. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004 110 : 2591 2596. (Pubitemid 39453007)
15. Alsheikh-Ali A, Homer M, Maddukuri P, Kalsmith B, Mark Estes NA III., Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2008 19 : 790 793.
16. Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M, Luise R, et al. Defibrillation testing at the time of implantation of cardioverter defibrillation in the clinical practice: A nation-wide survey. Europace 2007 9 : 540 543 (Pubitemid 47249446)
17. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, et al. Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008 5 : 387 390.
18. Gula LJ, Massel D, Krahn AD, Yee R, Skanes AC, Klein GJ. Is defibrillation testing still necessary? A decision analysis and Markov model. J Cardiovasc Electrophysiol 2008 19 : 400 405.
19. Panotopoulos P, Krum D, Axtell K, Dhala A, Sra J, Akhtar M, Deshpande S. Ventricular fibrillation sensing and detection by implantable defibrillators: Is one better than the others? A prospective, comparative study. J Cardiovasc Electrophysiol 2001 12 : 445 452. (Pubitemid 32324659)